PITTSBURGH, April 9, 2015 — ChemImage Sensor Systems (CISS™) today proudly introduces the launch of their newest product the VeroVision™ Mail Screener, which utilizes real-time shortwave infrared imaging sensor technology to detect hidden illicit drug substances. The initial public demonstration of this product will be at the American Jail Association’s 34th Annual Conference & Jail Expo in Charlotte, NC, from April 19th -22nd, 2015. The capabilities of the product will be displayed at the CISS exhibit at booth #229. Jeffrey Beckstead, PhD., Director of Product Development, will also be presenting the technology and its drug screening applications during the Exhibitor Showcase on Monday, April 20th at 1:00 pm.
The VeroVision Mail Screener scans articles of mail, and detects illicit drugs and common cutting agents. The system features a simple, one-click user interface that allows the operator to scan mail within seconds and clearly confirm the existence of illicit drug substances. Using shortwave near-infrared light, the system can reveal what is invisible to the human eye. The system incorporates advanced acquisition and processing methods to detect illicit substances and presents the detections to the mail screener.
“A known problem that correctional facilities face is the continued introduction of illicit materials through the mail which causes security issues and ultimately increased cost. Understanding this issue, we knew that by combining our imaging and processing expertise, and building upon our existing VeroVision hyperspectral imaging platform, we could develop a system in a rather short period of time to address this major security issue,” states Marie Molnar Hammond, Vice President of Marketing and Product Development, ChemImage.
A major emphasis on the product feasibility and design was to meet the demands of the correction’s market and make the product a simple and effective screening tool. We feel this goal has been met with the VeroVision Mail Screener.
“The introduction of contraband drugs through the mail is a growing problem in correctional facilities,” stated William Stickman, Retired Deputy Secretary Pa. Dept. of Corrections. “Use of the VeroVision technology will enable the facility mail inspectors to do a more thorough job of drug detection and save time.”
“Threat detection has been a major focus for ChemImage Corporation and its sensor company CISS,” says Matthew Nelson, Chief Scientist and Line of Business Manager, ChemImage Sensor Systems. “Extension of the VeroVision technology to illicit drug detection for corrections mail screening was a straightforward path from our standoff explosive and clandestine drug detection product line.”
“By adapting the VeroVision platform to the mail screening application, we are able to introduce the product’s feasibility into the correction’s market. The VeroVision Mail Screening product reduces the time to screen mail, while improving the detection capabilities over human screening.”
For more information on the VeroVision Mail Screener product or ChemImage Sensor Systems you can visit them during the AJA conference or on their website http://www.cisensorsystems.com/.
About ChemImage Sensor Systems
CISS develops innovative products that utilize patented imaging capabilities and leverage current in-the-field technologies to address the ever-changing landscape of drugs, chemical, biological and explosive (CBE) threats. CISS has developed a series of chemical imaging sensors for point, proximity, remote and standoff detection and identification in both fixed site and on-the-move configurations, in order to protect military troops, security personnel and citizens. For more information, visit the website at http://www.cisensorsystems.com/.
ChemImage Sensor Systems is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.
ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company’s proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.
ChemImage’s headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.